Semisynthetic neoclerodanes as kappa opioid receptor probes

被引:23
|
作者
Lovell, Kimberly M. [1 ]
Vasiljevik, Tamara [1 ]
Araya, Juan J. [1 ]
Lozama, Anthony [2 ]
Prevatt-Smith, Katherine M. [1 ]
Day, Victor W. [1 ]
Dersch, Christina M. [3 ]
Rothman, Richard B. [3 ]
Butelman, Eduardo R. [4 ]
Kreek, Mary Jeanne [4 ]
Prisinzano, Thomas E. [1 ]
机构
[1] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA
[2] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
[3] NIDA, Clin Psychopharmacol Sect, IRP, DHHS, Baltimore, MD 21224 USA
[4] Rockefeller Univ, Lab Biol Addict Dis, New York, NY USA
基金
美国国家科学基金会;
关键词
Natural product; Salvinorin A; Salvia divinorum; Kappa opioid receptor; Hallucinogen; Furan; SALVINORIN-A; SALVIA-DIVINORUM; NATURAL-PRODUCTS; LIGANDS; AGONIST; TRANSFORMATIONS; IDENTIFICATION; HALLUCINOGEN; ANTAGONISTS; DITERPENES;
D O I
10.1016/j.bmc.2012.02.040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Modification of the furan ring of salvinorin A (1), the main active component of Salvia divinorum, has resulted in novel neoclerodane diterpenes with opioid receptor affinity and activity. Conversion of the furan ring to an aldehyde at the C-12 position (5) has allowed for the synthesis of analogues with new carbon-carbon bonds at that position. Previous methods for forming these bonds, such as Grignard and Stille conditions, have met with limited success. We report a palladium catalyzed Liebeskind-Srogl cross-coupling reaction of a thioester and a boronic acid that occurs at neutral pH and ambient temperature to produce ketone analogs at C-12. To the best of our knowledge, this is the first reported usage of the Liebeskind-Srogl reaction to diversify a natural product scaffold. We also describe a one-step protocol for the conversion of 1 to 12-epi-1 (3) through microwave irradiation. Previously, this synthetically challenging process has required multiple steps. Additionally, we report in this study that alkene 9 and aromatic analogues 12, 19, 23, 25, and 26 were discovered to retain affinity and selectivity at kappa opioid receptors (KOP). Finally, we report that the furan-2-yl analog of 1 (31) has similar affinity to 1. Collectively, these findings suggest that different aromatic groups appended directly to the decalin core may be well tolerated by KOP receptors, and may generate further ligands with affinity and activity at KOP receptors. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3100 / 3110
页数:11
相关论文
共 50 条
  • [31] Kappa-opioid receptor ligands
    Husbands, SM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (12) : 1725 - 1741
  • [32] Molecular modeling on kappa opioid receptor and its interaction with nonpeptide kappa opioid agonists
    Liu, DX
    Jiang, HL
    Shen, JS
    Zhu, WL
    Zhao, L
    Chen, KX
    Ji, RY
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (02): : 131 - 136
  • [33] Modification of the furan ring of salvinorin A: Identification of a selective partial agonist at the kappa opioid receptor
    Beguin, Cecile
    Duncan, Katharine K.
    Munro, Thomas A.
    Ho, Douglas M.
    Xu, Wei
    Liu-Chen, Lee-Yuan
    Carlezon, William A., Jr.
    Cohen, Bruce M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (03) : 1370 - 1380
  • [34] The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies
    Dalefield, Martin L.
    Scouller, Brittany
    Bibi, Rabia
    Kivell, Bronwyn M.
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [35] New kappa opioid receptor from zebrafish Danio rerio
    Alvar Alvarez, Franscisco
    Rodriguez-Martin, Ivan
    Gonzalez-Nunez, Veronica
    Fernandez de Velasco, Ezequiel Marron
    Gonzalez Sarmiento, Rogelio
    Rodriguez, Raquel E.
    NEUROSCIENCE LETTERS, 2006, 405 (1-2) : 94 - 99
  • [36] Kappa-opioid ligands in the study and treatment of mood disorders
    Carlezon, William A., Jr.
    Beguin, Cecile
    Knoll, Allison T.
    Cohen, Bruce M.
    PHARMACOLOGY & THERAPEUTICS, 2009, 123 (03) : 334 - 343
  • [37] A single injection of a novel kappa opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats
    Morani, Aashish S.
    Schenk, Susan
    Prisinzano, Thomas E.
    Kivell, Bronwyn Maree
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (02): : 162 - 170
  • [38] Utilizing nature as a source of new probes for opioid pharmacology
    Lovell, Kimberly M.
    Simpson, Denise S.
    Cunningham, Christopher W.
    Prisinzano, Thomas E.
    FUTURE MEDICINAL CHEMISTRY, 2009, 1 (02) : 285 - 301
  • [39] Sex differences in kappa opioid pharmacology
    Rasakham, Khampaseuth
    Liu-Chen, Lee-Yuan
    LIFE SCIENCES, 2011, 88 (1-2) : 2 - 16
  • [40] Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands
    Polepally, Prabhakar R.
    White, Kate
    Vardy, Eyal
    Roth, Bryan L.
    Ferreira, Daneel
    Zjawiony, Jordan K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (10) : 2860 - 2862